Tampere University | ChronosHub Journal Finder

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on kustantajan kanssa sopimus, joka mahdollistaa artikkelin avoimen julkaisemisen ilman erillistä kirjoittajamaksua, kun vastuukirjoittaja on affilioitunut Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan. Sopimuskausi on 1.1.2025-31.12.2026. Katso ohjeet.
Tämä lehti on Plan S -yhteensopiva.

Tampere University Library’s agreement with the publisher allows corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital to publish open access in this journal without an article processing charge (APC). Agreement period is 1.1.2025-31.12.2026. Read instructions.
This journal is Plan S -compatible.

Go to Journal

Publisher: Wiley

Visit Publisher homepage Visit journal homepage

Oncology Pathology and Forensic Medicine

The Journal of Pathology aims to serve as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The main interests of the Journal lie in publishing studies that further our understanding the pathophysiological and pathogenetic mechanisms of human disease.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on kustantajan kanssa sopimus, joka mahdollistaa artikkelin avoimen julkaisemisen ilman erillistä kirjoittajamaksua, kun vastuukirjoittaja on affilioitunut Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan. Sopimuskausi on 1.1.2025 – 31.12.2026. Katso ohjeet.
Tämä lehti on Plan S -yhteensopiva.

Tampere University Library’s agreement with the publisher allows corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital to publish open access in this journal without an article processing charge (APC). Agreement period is 1.1.2025 – 31.12.2026. Read instructions.
This journal is Plan S -compatible.

Go to Journal

Publisher: Elsevier

Visit Publisher homepage Visit journal homepage

Oncology

The Lancet Oncology is recognized for providing a global, authoritative, and independent forum for the highest quality clinical oncology research and opinion. With an impact factor of 25.12, the journal ranks third out of 194 oncology journals worldwide, is the leading clinical research journal in oncology, and is in the top 0.5% of all scientific journals, of any discipline, globally (2012 Journal Citation Reports®, © Thomson Reuters 2013).The Lancet Oncology publishes original research, reviews, personal views, commentaries, and news across the global field of oncology. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks of submission and published first online on TheLancet.com before the print issue. Articles published in The Lancet Oncology regularly receive coverage in the mainstream print, online, and broadcast media.Visit www.TheLancet.com to find out more about The Lancet Oncology.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Go to Journal

Publisher: Oxford University Press

Visit Publisher homepage Visit journal homepage

Cancer Research Oncology

Oncology and hematology professionals are continuously charged with staying on the cutting–edge of new medical treatments and technologies to foster better cancer patient care and practice management. To that end, The Oncologist® is dedicated to translating the latest research developments into best multimodality practice.Established by oncologists for oncologists, the Journal is committed to helping physicians excel in a challenging and ever-changing environment; to ensure their patients’ rights to the highest level of care from screening and prevention to diagnosis, treatment and management of the disease.Designed specifically for the busy practitioner, The Oncologist is devoted to medical and practice issues for surgical, radiation, and medical oncologists. With emphasis on clear, concise interpretation, rather than data, the Journal's articles are meant to impact the practice of oncology and to facilitate significant communication in the introduction and application of new advancements.The Oncologist'sSenior Editors believe that the various oncology subspecialists should share the same information base and read the same journal. It is up to us, as leaders in this field, to defend the patient's needs and rights and to assure that the patient has an advocate. In order to do so, we have to be united and fully informed. We pledge to put the best and latest information on cancer management before our readership, to help prepare them for the future, and to do their best as a team to improve outcomes and quality of life for every patient.Manuscripts are reviewed by two or more field experts and, when accepted, are published expeditiously—generally within 12 weeks. When a contribution is of such relevance as to significantly impact public health, authors may request Fast Track Review for a Rapid Communication, in which case an editorial decision will be made within 2 weeks of submission.The Oncologist challenges its readers to understand what is new and better, to glimpse the future, not only in terms of research, but also in terms of new team approaches to disease management. In short, we want our readers to explore how cancer medicine could be and will be practiced now and throughout the 21st century.CORRESPONDENCEEditorial correspondence, including submissions for publication or letters to the Editor, should be addressed to the Executive Editor. Submissions for publication in the Fundamentals in Cancer Medicine section should also be addressed to the Executive Editor.Information for Authors can be found at the back of each issue, or contact the AlphaMed Press Editorial Office.Advertising: Correspondence and rate requests should be addressed to the Publisher.Change of Address notices: Both the subscriber's old and new address should be e-mailed to AlphaMed Press at least one month in advance. You can also mail the information to: AlphaMed Press, c/o Cambey & West, PO Box 412, Congers, New York 10920-9914 USA.

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on sopimus kustantajan kanssa. Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan affilioitunut vastuukirjoittaja saa 15 %:n alennuksen kirjoittajamaksusta. Sopimuskausi on 1.1.2024-31.12.2025. Katso ohjeet. Kirjasto voi mahdollisesti maksaa kirjoittajamaksun vuonna 2025. Katso OA-tukirahoituksen myöntökriteerit.

Tampere University Library has an agreement with the publisher. Corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital are entitled to 15% APC discount due to the agreement. Agreement period is 1.1.2024-31.12.2025. Read instructions. The Library may pay the article processing charge in 2025. Check all eligibility criteria for Open Access support funding.

Go to Journal

Publisher: SAGE Publications

Visit Publisher homepage Visit journal homepage

Oncology

The Journal is aimed at researchers and clinicians involved in the medical treatment of cancer and is a forum for publishing original research and reviews in this area. It will cover systemic cancer treatments including chemotherapy, endocrine therapy, biological therapy and immunotherapy, as well as adjuvant systemic therapy. All cancers will be covered including gynaecological cancers, lung cancer, gastrointestinal cancers, urological cancers, head and neck cancers, and skin cancer.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on kustantajan kanssa sopimus, joka mahdollistaa artikkelin avoimen julkaisemisen ilman erillistä kirjoittajamaksua, kun vastuukirjoittaja on affilioitunut Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan. Sopimuskausi on 1.1.2025-31.12.2026. Katso ohjeet.
Tämä lehti on Plan S -yhteensopiva.

Tampere University Library’s agreement with the publisher allows corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital to publish open access in this journal without an article processing charge (APC). Agreement period is 1.1.2025-31.12.2026. Read instructions.
This journal is Plan S -compatible.

Go to Journal

Publisher: AME Publishing

Visit Publisher homepage Visit journal homepage

Cancer Research Oncology Radiology Nuclear Medicine and imaging

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: SAGE Publications

Visit Publisher homepage Visit journal homepage

Cancer Research Genetics Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Elsevier

Visit Publisher homepage Visit journal homepage

Cancer Research Oncology

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on sopimus kustantajan kanssa. Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan affilioitunut vastuukirjoittaja saa 15 %:n alennuksen kirjoittajamaksusta. Sopimuskausi on 1.1.2024-31.12.2025. Katso ohjeet. Kirjasto voi mahdollisesti maksaa kirjoittajamaksun vuonna 2025. Katso OA-tukirahoituksen myöntökriteerit.

Tampere University Library has an agreement with the publisher. Corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital are entitled to 15% APC discount due to the agreement. Agreement period is 1.1.2024-31.12.2025. Read instructions. The Library may pay the article processing charge in 2025. Check all eligibility criteria for Open Access support funding.

Go to Journal

Publisher: Cell Press

Visit Publisher homepage

Cancer Research Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Go to Journal

Publisher: SAGE Publications

Visit Publisher homepage Visit journal homepage

Cancer Research Medicine(all)Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on kustantajan kanssa sopimus, joka mahdollistaa artikkelin avoimen julkaisemisen ilman erillistä kirjoittajamaksua, kun vastuukirjoittaja on affilioitunut Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan. Sopimuskausi on 1.1.2025-31.12.2026. Katso ohjeet.
Tämä lehti on Plan S -yhteensopiva.

Tampere University Library’s agreement with the publisher allows corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital to publish open access in this journal without an article processing charge (APC). Agreement period is 1.1.2025-31.12.2026. Read instructions.
This journal is Plan S -compatible.

Go to Journal

Publisher: Wiley Open Access

Visit Publisher homepage Visit journal homepage

Gastroenterology Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on kustantajan kanssa sopimus, joka mahdollistaa artikkelin avoimen julkaisemisen ilman erillistä kirjoittajamaksua, kun vastuukirjoittaja on affilioitunut Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan. Sopimuskausi on 1.1.2025 – 31.12.2026. Katso ohjeet.

Tampere University Library’s agreement with the publisher allows corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital to publish open access in this journal without an article processing charge (APC). Agreement period is 1.1.2025 – 31.12.2026. Read instructions.

Go to Journal

Publisher: Elsevier

Visit Publisher homepage Visit journal homepage

Oncology Urology

Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on kustantajan kanssa sopimus, joka mahdollistaa artikkelin avoimen julkaisemisen ilman erillistä kirjoittajamaksua, kun vastuukirjoittaja on affilioitunut Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan. Sopimuskausi on 1.1.2024-31.12.2025. Katso ohjeet.
Tämä lehti on Plan S -yhteensopiva.

Tampere University Library’s agreement with the publisher allows corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital to publish open access in this journal without an article processing charge (APC). Agreement period is 1.1.2024-31.12.2025. Read instructions.
This journal is Plan S -compatible.

Go to Journal

Publisher: Izdatel'stvo Meditsina Publishers

Cancer Research Oncology

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: VERDUCI PUBLISHER

Visit journal homepage View author guidelines View aims and scope

Oncology

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Baishideng Publishing Group

Visit Publisher homepage Visit journal homepage

Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Baishideng Publishing Group

Visit Publisher homepage Visit journal homepage

Gastroenterology Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Elmer Press

Visit Publisher homepage Visit journal homepage

Cancer Research Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Go to Journal

Publisher: BioMed Central

Visit Publisher homepage Visit journal homepage

Oncology Surgery

World Journal of Surgical Oncology is ready to accept papers on all aspects of surgical oncology and allied subjects.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Institutional Agreement

Tampereen yliopiston kirjastolla on sopimus kustantajan kanssa. Tampereen yliopistoon, Tampereen ammattikorkeakouluun tai Tampereen yliopistolliseen sairaalaan affilioitunut vastuukirjoittaja saa 15 %:n alennuksen kirjoittajamaksusta. Sopimuskausi on 1.1.2025 – 31.12.2025. Katso ohjeet. Kirjasto voi mahdollisesti maksaa kirjoittajamaksun vuonna 2025. Katso OA-tukirahoituksen myöntökriteerit.

Tampere University Library has an agreement with the publisher. Corresponding authors affiliated with Tampere University, Tampere University of Applied Sciences and Tampere University Hospital are entitled to 15% APC discount due to the agreement. Agreement period is 1.1.2025 – 31.12.2025. Read instructions. The Library may pay the article processing charge in 2025. Check all eligibility criteria for Open Access support funding.

Go to Journal

Publisher: Cancer Intelligence

Visit Publisher homepage Visit journal homepage View author guidelines View aims and scope

Cancer Research Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Unknown

Go to Journal

Publisher: Nature Research

Visit Publisher homepage Visit journal homepage

Oncology Pharmacology (medical)Radiology Nuclear Medicine and imaging

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Journal Guide

Following fields are empty!

Request Journal

The International Journal of Biological Markers

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

List Price

Institutional Agreement

The Journal of Pathology

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

List Price

List Price

Institutional Agreement

The Lancet Oncology

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

List Price

List Price

List Price

List Price

The Oncologist

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

Institutional Agreement

Therapeutic Advances in Medical Oncology

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

List Price

List Price

List Price

List Price

Institutional Agreement

Translational Cancer Research

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

Translational Oncogenomics

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

Translational Oncology

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

Institutional Agreement

Trends in Cancer

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

List Price

List Price

List Price

Tumori Journal

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

List Price

Institutional Agreement

United European Gastroenterology Journal

Compliant Options - Provided by Journal Checker Tool

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

List Price

Institutional Agreement

Urologic Oncology: Seminars and Original Investigations

Compliant Options - Provided by Journal Checker Tool